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Hypothalamic RIP-expressing neurons regulate energy balance, but the precise neural pathways and
neurotransmitters mediating this effect remain undetermined. Kong et al. (2012) now demonstrate that RIP
neurons regulate energy expenditure and BAT thermogenesis predominantly via a GABAergic arcuate-
paraventricular-hindbrain pathway.The hypothalamus is a critical regulator of
energy balance and glucose homeo-
stasis. Over the past 10–15 years a great
deal of attention has been devoted
to hypothalamic neurons that produce
agouti-related peptide (AgRP) and neu-
rons that express proopiomelanocortin
(POMC) in part because of the importance
of these neuronal populations in the inte-
gration of peripheral blood-born signals,
including endocrine signals and nutrients
(Williams and Elmquist, 2012; Sa´nchez-
Lasheras et al., 2010; Gao and Horvath,
2007). However, the hypothalamus con-
tains a variety of other neuronal systems,
and their relative contributions to the re-
gulation of energy balance remains in-
completely understood. In addition, a
better understanding of the complex
neuronal network that regulates appetite
and body weight is needed. In a recent
issue of Cell, Kong et al. (2012) mapped
the synaptic interactions of a subpopula-
tion of GABAergic neurons from the
arcuate nucleus (ARH) with other hypo-
thalamic and hindbrain pathways and
demonstrated the importance of these
neural circuits in the regulation of energy
expenditure and brown adipose tissue
(BAT) activity (Figure 1).Empirical experiments using physical
lesions of specific hypothalamic nuclei
and, more recently, genetic and optoge-
netic studies have shown the importance
of neurons within the ARH, the ventrome-
dial nucleus (VMH), the dorsomedial
nucleus (DMH), the paraventricular
nucleus (PVH), and the lateral hypotha-
lamic area (LHA) in the regulation of
feeding and body weight. Lowell and
colleagues used the cre-loxP approach
to specifically delete GABAergic neuro-
transmission in rat insulin promoter
(RIP)-expressing neurons; this neuronal
population is distinct from the POMC
and AgRP neurons and is present in the
ARH, VMH, and DMH (Kong et al., 2012).
Mice lacking synaptic release of GABA
from RIP-containing neurons (Rip-Cre;
Vgatflox/flox mice) display higher body
weights and a marked increase in fat
mass. The mutant mice also show a
greater sensitivity to weight gain on a
high-fat diet (HFD). However, the elevated
body weight in chow and HFD-fed mice
could not be explained by changes in
food intake or locomotor activity, but
Kong et al. found a marked decrease in
oxygen consumption and altered BAT
thermogenesis, revealed by reduced in-terscapular temperature and UCP1 ex-
pression, which may be partially respon-
sible for the reduced energy expenditure
observed in mice lacking GABA neuro-
transmission in RIP neurons. In contrast,
blockade of glutamatergic release from
RIP-expressing neurons did not affect
energy balance, indicating that GABA is
the major neurotransmitter involved in
this process.
One of the most important functions of
RIP neurons is to mediate leptin’s effect
on energy balance (Covey et al., 2006).
Kong et al. (2012) show that the ability of
leptin to reduce body weight requires
GABA release from RIP-containing neu-
rons. In the absence of GABA neurotrans-
mission, leptin does not reduce body
weight, likely due to an inability to
increase energy expenditure and BAT
activity. RIP neurons are primarily present
in the ARH, VMH, and DMH, and each of
these nuclei is a direct target for leptin
(Patterson et al., 2011). To define the
RIP neurons responsible for the bulk of
leptin action, Kong et al. (2012) examined
leptin-induced pSTAT3, a marker of leptin
receptor activation, in Rip-Cre; lox-GFP
mice and found cells coexpressing
pSTAT3 and Cre mainly in the ARH andNovember 7, 2012 ª2012 Elsevier Inc. 557
Figure 1. RIP Neurons Selectively Regulate Energy Expenditure and BAT Activity via
a GABAergic ARH-PVH-Hindbrain Pathway
A distinct population of neurons in the arcuate nucleus (ARH) expresses RIP and represents a major route
for regulation of energy expenditure by leptin, as demonstrated in the study by Kong et al. (2012). These
neurons send direct projections to discrete populations of neurons located in the medial parvicellular part
of the paraventicular nucleus (PVHmpv), where they release the inhibitory neurotransmitter GABA. The RIP
target PVHmpv neurons then send functional efferent connections to the nucleus of the tractus solitarius
(NTS), which in return sends GABAergic projections to the raphe pallidus (RPa), another hindbrain nucleus
known to regulate sympathetic outflow to brown adipose tissue (BAT).
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matergic and not GABAergic, the authors
conclude that all leptin-responsive Rip-
Cre neurons are located in the ARH.
To further demonstrate the relative con-
tribution of ARH RIP neurons to energy
balance regulation, Lowell and colleagues
used DREADD (designer receptors ex-
clusively activated by designer drugs)
technology to specifically control the acti-
vation of this neuronal population. They
found that chronic stimulation of ARH
neurons increases oxygen consumption
and BAT activity and that this effect is
blunted in the absence of GABA release
from ARH RIP neurons. Arcuate neurons
project extensively to various parts of
the brain (Bouret et al., 2004). The re-
searchers next pursued creative appro-
aches combining electrophysiological,
tract-tracing, and optogenetic circuit
mapping methods to delineate neural
circuits involved in BAT thermogenesis.
They found that the vast majority of
GABAergic leptin-responsive RIP neu-
rons in the ARH provide direct functional
projections to the PVH. This is of partic-
ular interest because the PVH is the
most thoroughly characterized hypotha-
lamic interface between the endocrine
and autonomic systems that influence
energy balance (Sawchenko, 1998). Of
fundamental importance to the function
of the PVH are its parvicellular neurons
that regulate sympathetic outflow and
BAT function. Extending these findings,
Kong et al. (2012) demonstrate that
neurons located in themedial parvicellular558 Cell Metabolism 16, November 7, 2012 ªpart of the PVH (PVHmpv) receive direct
projections from GABAergic ARH RIP
neurons and in return send efferent
connections to the nucleus of the tractus
solitarius (NTS). They further show that
the neural circuits linking the NTS with
BAT involve GABAergic projections to
the raphe pallidus (RPa), a hindbrain
nucleus that contains BAT sympathetic
preautonomic neurons.
Like most new and exciting observa-
tions, the current study by Kong et al.
(2012) prompts many questions for future
investigation. Perhaps the most intriguing
finding of this paper is that GABAergic
ARH RIP neural circuits selectively drive
energy expenditure but not other compo-
nents of energy balance such as food
intake. However, it is still not clear which
specific GABAergic ARH neuronal popu-
lation influences energy expenditure. The
ARH contains a plethora of intermingled
and molecularly defined cell types, each
characterized by the expression of spe-
cific neuropeptides. The present study
rules out the involvement of AgRP/NPY
neurons, a well-characterized population
of GABAergic neurons in the ARH. How-
ever, neuropeptides such as galanin,
dynorphin, enkephalin, growth-hormone
releasing hormone, neurotensin, neuro-
medin U, and somatostatin (Lantos et al.,
1995) are also expressed in subpopula-
tions of arcuate neurons, and their
specific contribution to energy expendi-
ture remains to be established.
The study by Lowell and colleagues
reinforces the concept that a sophisti-2012 Elsevier Inc.cated network of neural circuits is respon-
sible for the regulation of energy expendi-
ture. However, these circuits are probably
even more complex than the ones
described in this study. For example, the
DMH has long been considered an impor-
tant component of thermogenic BAT
circuits. Although Kong et al. (2012) report
that the DMH only receives a few
GABAergic projections from ARH RIP
neurons, it may still mediate some of the
thermogenic effects of leptin. Consistent
with this idea, a recent study showed that
DMH neurons expressing leptin receptor
project transsynaptically to the BAT via
projections to theRPa (Zhang et al., 2011).
In the face of the growing obesity
epidemic and with the realization that
obesity is an induced disease of the brain,
it is critical that we acquire a better under-
standing of the neural circuits and
networks involved in energy balance re-
gulation, which, in turn, will make it
possible to define targets for the develop-
ment of more specific medicines. The
study by Kong et al. (2012) reveals the
neural substrates that are selectively
involved in energy expenditure and BAT
thermogenesis, uncovers a significant
piece of the obesity puzzle, and will
undoubtedly have important implications
for metabolic disease.
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